Acne Vulgaris Treatment Update
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY. With the heavy acne tool box these days, how do you pick which medications to use? …
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY. With the heavy acne tool box these days, how do you pick which medications to use? … 
This article provides practical pearls for performing full body skin exams as shared by a panel of dermatology nurse practitioners (NPs) and physician assistants (PAs) during the 2022 DERM NP/PA CME conference.
Let’s Start with the Basics
What happens before we enter the room?
Before entering the room, it’s always best to:
Review the patient’s chart for pertinent medical hist … 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Mark Gimbel, surgical oncologist with Banner MD Anderson Cancer Center, on how molecular tools are revolutionizing how melanoma is diagnosed, treated and prognosticated. Watch Dr. Gimbel explain the current tests on the market and … 
A branch of which of the following nerves is most crucial to anesthetize prior to the excision of this squamous cell carcinoma?
A. Auriculotemporal nerve
B. Buccal nerve
C. Greater auricular nerve
D. Inferior alveolar nerve
E. Lingual nerve
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety profile of semaglutide is similar to … 